Advertisement

Apoptosis

pp 1–10 | Cite as

Matrix metalloproteinase 9 induces keratinocyte apoptosis through FasL/Fas pathway in diabetic wound

  • Ying Liang
  • Chuan Yang
  • Yongqing Lin
  • Yasir Parviz
  • Kan Sun
  • Wei Wang
  • Meng RenEmail author
  • Li YanEmail author
Article

Abstract

Apoptosis is a mechanism to remove unwanted cells in the tissue. In diabetic wound, which is characterized by delayed healing process, excessive apoptosis is documented and plays a crucial role. Matrix metalloproteinase 9 (MMP9), which is elevated in non-healed diabetic wound, is necessary for healing process but its abnormality resulted in a delayed healing. The classical function of MMP9 is the degradation of extracellular matrix (ECM). However, there is some literature evidence that MMP9 triggers cell apoptosis. Whether the excessive MMP9 contributes to epidermis cell apoptosis in delayed healing diabetic wound and the underlying mechanisms is not clear. In this study, we aimed to explore whether MMP9 induced keratinocyte apoptosis and investigate the plausible mechanisms. Our in vitro study showed that advanced glycation end products (AGEs) induced keratinocyte apoptosis and enhanced MMP9 level. Besides, MMP9, both intra-cellular expressions and extra-cellular supplement, promoted cell apoptosis. Further, MMP9 resulted in an increased expression of FasL, other than Fas and p53. These findings identified a novel effect that MMP9 exerted in delayed diabetic wound healing, owing to a pro-apoptotic effect on keratinocyte, which was mediated by an increase of FasL expression. This study increases understanding of elevated MMP9 which is involved in diabetic wound repair and offers some insights into novel future therapies.

Keywords

Advanced glycation end products Matrix metalloproteinase 9 Apoptosis Signaling pathway 

Notes

Acknowledgements

This study was funded by the National Natural Science Foundation of China (81770827, 81471034).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Supplementary material

10495_2019_1536_MOESM1_ESM.tif (19.4 mb)
Supplemental figure (not mentioned in the article, just to identify keratinocyte). a. Human keratinocytes culture (200×). b. Keratin secretion observed by microscope. (A). Keratin images in normal microscope (100×). (B). Keratin images in immunofluorescence microscopy (100×). (C). Cell nucleus images in immunofluorescence microscopy (100×). (TIF 19888 KB)

References

  1. 1.
    Singh N, Armstrong DG, Lipsky BA (2005) Preventing foot ulcers in patients with diabetes. JAMA 293(2):217–228CrossRefGoogle Scholar
  2. 2.
    Muller IS, de Grauw WJ, van Gerwen WH et al (2002) Foot ulceration and lower limb amputation in type 2 diabetic patients in dutch primary health care. Diabetes Care 25(3):570–574CrossRefGoogle Scholar
  3. 3.
    American Diabetes Association (2013) Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36(4):1033–1046CrossRefGoogle Scholar
  4. 4.
    Rai NK, Tripathi K, Sharma D et al (2005) Apoptosis: a basic physiologic process in wound healing. Int J Low Extrem Wounds 4(3):138–144CrossRefGoogle Scholar
  5. 5.
    Greenhalgh DG (1998) The role of apoptosis in wound healing. Int J Biochem Cell Biol 30(9):1019–1030CrossRefGoogle Scholar
  6. 6.
    Edwards M, Jones D (2001) Programmed cell death in human acute cutaneous wounds. J Cutan Pathol 28:151–155CrossRefGoogle Scholar
  7. 7.
    Tuan TL, NichterL S (1998) The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 4:19–24CrossRefGoogle Scholar
  8. 8.
    Kane CD, Greenhalgh DG (2000) Expression and localization of p53 and bcl-2 in healing wounds in diabetic and nondiabetic mice. Wound Repair Regen 8(1):45–58CrossRefGoogle Scholar
  9. 9.
    Darby IA, Bisucci T, Hewitson TD et al (1997) Apoptosis is increased in a model of diabetes-impaired wound healing in genetically diabetic mice. Int J Biochem Cell Biol 29(1):191–200CrossRefGoogle Scholar
  10. 10.
    Bhan S, Mitra R, Arya AK et al (2013) A study on evaluation of apoptosis and expression of bcl-2-related marker in wound healing of streptozotocin-induced diabetic rats. ISRN Dermatol 2013:739054CrossRefGoogle Scholar
  11. 11.
    Ponugoti B, Dong G, Graves DT (2012) Role of forkhead transcription factors in diabetes-induced oxidative stress. Exp Diabetes Res 2012:939751CrossRefGoogle Scholar
  12. 12.
    Wang XJ, Han G, Owens P et al (2006) Role of TGF beta-mediated inflammation in cutaneous wound healing. J Invest Dermatol Symp Proc 11(1):112–117CrossRefGoogle Scholar
  13. 13.
    Maas-Szabowski N, Starker A, Fusenig NE (2003) Epidermal tissue regeneration and stromal interaction in HaCaT cells is initiated by TGF-alpha. J Cell Sci 116(pt 14):2937–2948CrossRefGoogle Scholar
  14. 14.
    Bandyopadhyay B, Fan J, Guan S et al (2006) A “traffic control” role for TGFbeta3: orchestrating dermal and epidermal cell motility during wound healing. J Cell Biol 172(7):1093–1105CrossRefGoogle Scholar
  15. 15.
    Kawai K, Kageyama A, Tsumano T et al (2008) Effects of adiponectin on growth and differentiation of human keratinocytes-implication of impaired wound healing in diabetes. Biochem Biophys Res Commun 374(2):269–273CrossRefGoogle Scholar
  16. 16.
    Hu SC, Lan CE (2016) High-glucose environment disturbs the physiologic functions of keratinocytes: focusing on diabetic wound healing. J Dermatol Sci 84(2):121–127CrossRefGoogle Scholar
  17. 17.
    Ayuk SM, Abrahamse H, Houreld NN (2016) The role of matrix metalloproteinases in diabetic wound healing in relation to photobiomodulation. J Diabetes Res 2016:2897656CrossRefGoogle Scholar
  18. 18.
    López-López N, González-Curiel I, Treviño-Santa Cruz MB et al (2014) Expression and vitamin D-mediated regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy skin and in diabetic foot ulcers. Arch Dermatol Res 306(9):809–821CrossRefGoogle Scholar
  19. 19.
    Ladwig GP, Robson MC, Liu R et al (2002) Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Rep Reg 10:26–37CrossRefGoogle Scholar
  20. 20.
    Muller M, Trocme C, Lardy B et al (2008) Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing. Diabet Med 25(4):419–426CrossRefGoogle Scholar
  21. 21.
    Liu Y, Min D, Bolton T et al (2009) Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care 32(1):117–119CrossRefGoogle Scholar
  22. 22.
    Hoehna Y, Uckermann O, Luksch H et al (2012) Matrix metalloproteinase 9 regulates cell death following pilocarpine-induced seizures in the developing brain. Neurobiol Dis 48(3):339–347CrossRefGoogle Scholar
  23. 23.
    Manabe S, Gu Z, Lipton SA (2005) Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. Invest Ophthalmol Vis Sci 46(12):4747–4753CrossRefGoogle Scholar
  24. 24.
    Tran ED, DeLano FA, Schmid-Schonbein GW (2010) Enhanced matrix metalloproteinase activity in the spontaneously hypertensive rat: VEGFR-2 cleavage, endothelial apoptosis, and capillary rarefaction. J Vasc Res 47(5):423–431CrossRefGoogle Scholar
  25. 25.
    Xu J, Liu H, Wu Y et al (2011) Proapoptotic effect of metalloproteinase 9 secreted by trophoblasts on endothelial cells. J Obstet Gynaecol Res 37(3):187–194CrossRefGoogle Scholar
  26. 26.
    Bhagavathula N, Nerusu KC, Lal A et al (2004) Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytes. J Invest Dermatol 122(1):130–139CrossRefGoogle Scholar
  27. 27.
    O’Toole EA, van Koningsveld R, Chen M et al (2008) Hypoxia induces epidermal keratinocyte matrix metalloproteinase-9 secretion via the protein kinase C pathway. J Cell Physiol 214(1):47–55CrossRefGoogle Scholar
  28. 28.
    Zhu P, Yang C, Chen LH et al (2011) Impairment of human keratinocyte mobility and proliferation by advanced glycation end products-modified BSA. Arch Dermatol Res 303(5):339–350CrossRefGoogle Scholar
  29. 29.
    Long M, Rojo de la Vega M, Wen Q et al (2016) An essential role of NRF2 in diabetic wound healing. Diabetes 65(3):780–793CrossRefGoogle Scholar
  30. 30.
    Hozzein WN, Badr G, Al Ghamdi AA et al (2015) Topical application of propolis enhances cutaneous wound healing by promoting TGF-beta/Smad-mediated collagen production in a streptozotocin-induced type I diabetic mouse model. Cell Physiol Biochem 37(3):940–954CrossRefGoogle Scholar
  31. 31.
    Dinh T, Tecilazich F, Kafanas A et al (2012) Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes 61(11):2937–2947CrossRefGoogle Scholar
  32. 32.
    Lobmann R, Ambrosch A, Schultz G et al (2002) Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 45(7):1011–1016CrossRefGoogle Scholar
  33. 33.
    Reiss MJ, Han YP, Garcia E, Goldberg M et al (2010) Matrix metalloproteinase-9 delays wound healing in a murine wound model. Surgery 147(2):295–302CrossRefGoogle Scholar
  34. 34.
    Mannello F, Luchetti F, Falcieri E et al (2005) Multiple roles of matrix metalloproteinases during apoptosis. Apoptosis 10(1):19–24CrossRefGoogle Scholar
  35. 35.
    Kowluru RA (2010) Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras. Invest Ophthalmol Vis Sci 51(8):4320–4326CrossRefGoogle Scholar
  36. 36.
    Sung PH, Chua S, Chen KH et al (2018) Role of double knockdown of tPA and MMP-9 on regulating the left ventricular function and remodeling followed by transverse aortic constriction-induced hypertrophic cardiomyopathy in mice. Am J Transl Res 10(9):2781–2795Google Scholar
  37. 37.
    Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92(8):827–839CrossRefGoogle Scholar
  38. 38.
    Arya AK, Tripathi R, Kumar S et al (2014) Recent advances on the association of apoptosis in chronic non healing diabetic wound. World J Diabetes 5(6):756–762CrossRefGoogle Scholar
  39. 39.
    Hoke GD, Ramos C, Hoke NN et al (2016) Atypical diabetic foot ulcer keratinocyte protein signaling correlates with impaired wound healing. J Diabetes Res 2016:1586927CrossRefGoogle Scholar
  40. 40.
    Gutierrez-Steil C, Wrone-Smith T, Sun X, Krueger JG et al (1998) Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). J Clin Invest 101(1):33–39CrossRefGoogle Scholar
  41. 41.
    Berthou C, Michel L, Soulie A et al (1997) Acquisition of granzyme B and Fas ligand proteins by human keratinocytes contributes to epidermal cell defense. J Immunol 159(11):5293–5300Google Scholar
  42. 42.
    Arnold R, Seifert M, Asadullah K, Volk HD (1999) Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines. J Immunol 162(12):7140–7147Google Scholar
  43. 43.
    Leverkus M, Yaar M, Gilchrest BA (1997) Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Exp Cell Res 232(2):255–262CrossRefGoogle Scholar
  44. 44.
    Hill LL, Ouhtit A, Loughlin SM et al (1999) Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science 285(5429):898–900CrossRefGoogle Scholar
  45. 45.
    Viard-Leveuqle I, Bullani RR, Meda P et al (2003) Intracellular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditions. J Biol Chem 278(18):16183–16188CrossRefGoogle Scholar
  46. 46.
    Galkowska H, Olszewsk WL, Wojewodzka U et al (2003) Expression of apoptosis and cell cycle-related proteins in epidermis of venous leg and diabetic foot ulcers. Surgery 134(2):213–220CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Endocrinology, Sun Yat-sen Memorial HospitalSun Yat-sen UniversityGuangzhouChina
  2. 2.Department of Cardiology, Sun Yat-sen Memorial HospitalSun Yat-sen UniversityGuangzhouChina
  3. 3.Division of Cardiology, Center for Interventional Vascular Therapy, New York-Presbyterian HospitalColumbia UniversityNew YorkUSA

Personalised recommendations